Michael King, CFO of SAB Biotherapeutics SABS, has filed 1 purchase and 0 sales on the open market. The latest trade was on 24/02/21.

MK

MK

Michael King

CFO

Company

SAB Biotherapeutics SABS

First filing

23/11/03

Trades

3 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

24/02/21

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
SAB BiotherapeuticsSABS	Open-market buy	23/11/30	23/11/30	5,000 sh	$0.90	$4,500	No record